I agree, without some solid coordination with the FDA, this
I agree, without some solid coordination with the FDA, this would be a huge risk. For the M/M trial, they clearly discussed if they should file an EUA and were told not to, and that is what they did. It could be the frustration is so high that possibly the FDA is not approving the CD16 protocol and that was the last straw? I doubt it. I think there has been huge pressure on the FDA from many doctors to get an EUA ASAP. Is it odd that cytodyn would not put out a PR that they did in fact file EUA's before announcing a CC? Are they assuming the FDA will make some decision about the EUA (if filed) prior to the CC? Is this just a promised update CC and we are reading too much into it?
(most likely)
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sentry Tire Introduces Innovative Product Expansions Sentry Tire & Rubber LLC has announced a significant expansion of its product lineup. This includes cutting edges specifically designed for loaders and the introduction of two new rubber compounds: WR (Wear Resistant) for improved longevity and LH (Low Heat) to reduce heat buildup during operation. These advancements...
Continue Reading
Jade Power Trust’s Recent Stock Option Grant Jade Power Trust, also known as Jade Power, has recently taken an important step by granting stock options to its board of directors. Effective February 24, 2025, the Trust granted a total of 889,194 incentive stock options, a decision aimed at fostering a sense of ownership among its leadership. Details of the Stock Options...
Continue Reading
Examining Recent Options Activity of Advanced Micro Devices In the realm of financial investments, Advanced Micro Devices has seen a notable uptick in unusual options activity. The analysis of historical options trades for Advanced Micro Devices (NASDAQ: AMD) indicates a significant interest among traders, with 127 notable trades recorded recently. Diving deeper into...
Continue Reading
Important Class Action Alert for SelectQuote Investors Kahn Swick & Foti, LLC, led by former Attorney General Charles C. Foti, Jr., is reaching out to investors affected by SelectQuote, Inc. (NYSE: SLQT). The firm is reminding potential claimants that those who experienced losses exceeding $100,000 have until October 10, 2025, to apply as lead plaintiffs in an ongoing...
Continue Reading
What’s Happening with Robinhood Stock? Robinhood Markets, Inc. (NASDAQ: HOOD) has seen its share price decline recently, with reports indicating a drop of over 10% in the past month. Investors and traders are keenly watching this development as they assess the company's future performance. Current Stock Performance The latest data shows that HOOD shares have been...
Continue Reading
